Form EFFECT Outlook Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 25, 2023 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets
- InvestorNewsBreaks – Market Street Capital Inc. Helps Founders Navigate Expanding Private Credit Landscape
- Holladay Distillery Helps Bring Made for KC Barbecue Championship to Weston
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share